Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Ph.D., University of North Carolina at Chapel Hill 2004
• 

  Duke Appointment History

  • Instructor in the Department of Surgery, Surgery, Surgical Sciences, Surgery 2018
• 

  Leadership & Clinical Positions at Duke

  • Director of Gene Therapy
    Translating Duke Health Scholar
    Professor
    Department of Surgery
    Department of Molecular Genetics & Microbiology
    Department of Biomedical Engineering
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Albright, Blake H., Katherine E. Simon, Minakshi Pillai, Garth W. Devlin, and Aravind Asokan. “Modulation of Sialic Acid Dependence Influences the Central Nervous System Transduction Profile of Adeno-associated Viruses..” J Virol 93, no. 11 (June 1, 2019). https://doi.org/10.1128/JVI.00332-19.
       Full Text  Link to Item
    • Nelson, Christopher E., Yaoying Wu, Matthew P. Gemberling, Matthew L. Oliver, Matthew A. Waller, Joel D. Bohning, Jacqueline N. Robinson-Hamm, et al. “Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy..” Nat Med 25, no. 3 (March 2019): 427–32. https://doi.org/10.1038/s41591-019-0344-3.
       Full Text  Link to Item
    • Mestre, Humberto, Lauren M. Hablitz, Anna Lr Xavier, Weixi Feng, Wenyan Zou, Tinglin Pu, Hiromu Monai, et al. “Aquaporin-4-dependent glymphatic solute transport in the rodent brain..” Elife 7 (December 18, 2018). https://doi.org/10.7554/eLife.40070.
       Full Text  Link to Item
    • Meganck, Rita M., Erin K. Borchardt, Ruth M. Castellanos Rivera, Miranda L. Scalabrino, Jeremy E. Wilusz, William F. Marzluff, and Aravind Asokan. “Tissue-Dependent Expression and Translation of Circular RNAs with Recombinant AAV Vectors In Vivo..” Molecular Therapy. Nucleic Acids 13 (December 2018): 89–98. https://doi.org/10.1016/j.omtn.2018.08.008.
       Full Text
    • Castle, Michael J., Yuhsiang Cheng, Aravind Asokan, and Mark H. Tuszynski. “Physical positioning markedly enhances brain transduction after intrathecal AAV9 infusion..” Science Advances 4, no. 11 (November 14, 2018). https://doi.org/10.1126/sciadv.aau9859.
       Full Text
    • Tse, Longping V., Sven Moller-Tank, Rita M. Meganck, and Aravind Asokan. “Mapping and Engineering Functional Domains of the Assembly-Activating Protein of Adeno-associated Viruses..” J Virol 92, no. 14 (July 15, 2018). https://doi.org/10.1128/JVI.00393-18.
       Full Text  Link to Item
    • Crowther, Andrew J., Szu-Aun Lim, Brent Asrican, Blake H. Albright, Josh Wooten, Chia-Yu Yeh, Hechen Bao, et al. “An Adeno-Associated Virus-Based Toolkit for Preferential Targeting and Manipulating Quiescent Neural Stem Cells in the Adult Hippocampus..” Stem Cell Reports 10, no. 3 (March 2018): 1146–59. https://doi.org/10.1016/j.stemcr.2018.01.018.
       Full Text
    • Albright, Blake H., Claire M. Storey, Giridhar Murlidharan, Ruth M. Castellanos Rivera, Garrett E. Berry, Victoria J. Madigan, and Aravind Asokan. “Mapping the Structural Determinants Required for AAVrh.10 Transport across the Blood-Brain Barrier..” Molecular Therapy : The Journal of the American Society of Gene Therapy 26, no. 2 (February 2018): 510–23. https://doi.org/10.1016/j.ymthe.2017.10.017.
       Full Text
    • Burwitz, Benjamin J., Jochen M. Wettengel, Martin A. Mück-Häusl, Marc Ringelhan, Chunkyu Ko, Marvin M. Festag, Katherine B. Hammond, et al. “Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques..” Nat Commun 8, no. 1 (December 15, 2017). https://doi.org/10.1038/s41467-017-01953-y.
       Full Text  Link to Item
    • Guo, Jiami, James M. Otis, Holden Higginbotham, Chase Monckton, JrGang Cheng, Aravind Asokan, Kirk Mykytyn, Tamara Caspary, Garret D. Stuber, and E. S. Anton. “Primary Cilia Signaling Shapes the Development of Interneuronal Connectivity..” Dev Cell 42, no. 3 (August 7, 2017): 286-300.e4. https://doi.org/10.1016/j.devcel.2017.07.010.
       Full Text  Link to Item
    • Tse, Longping Victor, Kelli A. Klinc, Victoria J. Madigan, Ruth M. Castellanos Rivera, Lindsey F. Wells, L Patrick Havlik, J Kennon Smith, Mavis Agbandje-McKenna, and Aravind Asokan. “Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion..” Proc Natl Acad Sci U S A 114, no. 24 (June 13, 2017): E4812–21. https://doi.org/10.1073/pnas.1704766114.
       Full Text  Link to Item
    • Borchardt, Erin K., Rita M. Meganck, Heather A. Vincent, Christopher B. Ball, Silvia B. V. Ramos, Nathaniel J. Moorman, William F. Marzluff, and Aravind Asokan. “Inducing circular RNA formation using the CRISPR endoribonuclease Csy4..” Rna 23, no. 5 (May 2017): 619–27. https://doi.org/10.1261/rna.056838.116.
       Full Text  Link to Item
    • Tarantal, Alice F., C Chang I. Lee, Michele L. Martinez, Aravind Asokan, and R Jude Samulski. “Systemic and Persistent Muscle Gene Expression in Rhesus Monkeys with a Liver De-Targeted Adeno-Associated Virus Vector..” Human Gene Therapy 28, no. 5 (May 2017): 385–91. https://doi.org/10.1089/hum.2016.130.
       Full Text
    • Zeng, Cheng, Sven Moller-Tank, Aravind Asokan, and Bogdan Dragnea. “Probing the Link among Genomic Cargo, Contact Mechanics, and Nanoindentation in Recombinant Adeno-Associated Virus 2..” The Journal of Physical Chemistry. B 121, no. 8 (March 2017): 1843–53. https://doi.org/10.1021/acs.jpcb.6b10131.
       Full Text
    • Berry, Garrett Edward, and Aravind Asokan. “Cellular transduction mechanisms of adeno-associated viral vectors..” Current Opinion in Virology 21 (December 2016): 54–60. https://doi.org/10.1016/j.coviro.2016.08.001.
       Full Text
    • Tseng, Yu-Shan, Kim Van Vliet, Lavanya Rao, Robert McKenna, Barry J. Byrne, Aravind Asokan, and Mavis Agbandje-McKenna. “Generation and characterization of anti-Adeno-associated virus serotype 8 (AAV8) and anti-AAV9 monoclonal antibodies..” Journal of Virological Methods 236 (October 2016): 105–10. https://doi.org/10.1016/j.jviromet.2016.07.009.
       Full Text
    • Murlidharan, Giridhar, Andrew Crowther, Rebecca A. Reardon, Juan Song, and Aravind Asokan. “Glymphatic fluid transport controls paravascular clearance of AAV vectors from the brain..” Jci Insight 1, no. 14 (September 8, 2016). https://doi.org/10.1172/jci.insight.88034.
       Full Text
    • Murlidharan, Giridhar, Kensuke Sakamoto, Lavanya Rao, Travis Corriher, Dan Wang, Guangping Gao, Patrick Sullivan, and Aravind Asokan. “CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV Vector..” Mol Ther Nucleic Acids 5, no. 7 (July 19, 2016). https://doi.org/10.1038/mtna.2016.49.
       Full Text  Link to Item
    • Pierson, Elizabeth E., David Z. Keifer, Aravind Asokan, and Martin F. Jarrold. “Resolving Adeno-Associated Viral Particle Diversity With Charge Detection Mass Spectrometry..” Anal Chem 88, no. 13 (July 5, 2016): 6718–25. https://doi.org/10.1021/acs.analchem.6b00883.
       Full Text  Link to Item
    • Madigan, Victoria J., and Aravind Asokan. “Engineering AAV receptor footprints for gene therapy..” Current Opinion in Virology 18 (June 2, 2016): 89–96. https://doi.org/10.1016/j.coviro.2016.05.001.
       Full Text
    • Huang, Lin-Ya, Ami Patel, Robert Ng, Edward Blake Miller, Sujata Halder, Robert McKenna, Aravind Asokan, and Mavis Agbandje-McKenna. “Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site..” J Virol 90, no. 11 (June 1, 2016): 5219–30. https://doi.org/10.1128/JVI.00161-16.
       Full Text  Link to Item
    • Leeuw, Charles N. de, Andrea J. Korecki, Garrett E. Berry, Jack W. Hickmott, Siu Ling Lam, Tess C. Lengyell, Russell J. Bonaguro, et al. “rAAV-compatible MiniPromoters for restricted expression in the brain and eye..” Mol Brain 9, no. 1 (May 10, 2016). https://doi.org/10.1186/s13041-016-0232-4.
       Full Text  Link to Item
    • Vance, Melisa, Telmo Llanga, Will Bennett, Kenton Woodard, Giridhar Murlidharan, Neil Chungfat, Aravind Asokan, et al. “AAV Gene Therapy for MPS1-associated Corneal Blindness..” Scientific Reports 6 (February 22, 2016). https://doi.org/10.1038/srep22131.
       Full Text
    • Li, Chengwen, Shuqing Wu, Blake Albright, Matthew Hirsch, Wuping Li, Yu-Shan Tseng, Mavis Agbandje-McKenna, Scott McPhee, Aravind Asokan, and R Jude Samulski. “Development of Patient-specific AAV Vectors After Neutralizing Antibody Selection for Enhanced Muscle Gene Transfer..” Molecular Therapy : The Journal of the American Society of Gene Therapy 24, no. 1 (February 2016): 53–65. https://doi.org/10.1038/mt.2015.134.
       Full Text
    • Nelson, Christopher E., Chady H. Hakim, David G. Ousterout, Pratiksha I. Thakore, Eirik A. Moreb, Ruth M. Castellanos Rivera, Sarina Madhavan, et al. “In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy..” Science 351, no. 6271 (January 22, 2016): 403–7. https://doi.org/10.1126/science.aad5143.
       Full Text  Link to Item
    • Berry, Garrett E., and Aravind Asokan. “Chemical Modulation of Endocytic Sorting Augments Adeno-associated Viral Transduction..” The Journal of Biological Chemistry 291, no. 2 (January 2016): 939–47. https://doi.org/10.1074/jbc.M115.687657.
       Full Text
    • Borchardt, Erin K., Leonidas A. Vandoros, Michael Huang, Patrick E. Lackey, William F. Marzluff, and Aravind Asokan. “Controlling mRNA stability and translation with the CRISPR endoribonuclease Csy4..” Rna (New York, N.Y.) 21, no. 11 (November 2015): 1921–30. https://doi.org/10.1261/rna.051227.115.
       Full Text
    • Schreiber, Claire A., Toshie Sakuma, Yoshihiro Izumiya, Sara J. Holditch, Raymond D. Hickey, Robert K. Bressin, Upamanyu Basu, Kazunori Koide, Aravind Asokan, and Yasuhiro Ikeda. “An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses..” Plos Pathogens 11, no. 8 (August 5, 2015). https://doi.org/10.1371/journal.ppat.1005082.
       Full Text
    • Tse, Longping V., Sven Moller-Tank, and Aravind Asokan. “Strategies to circumvent humoral immunity to adeno-associated viral vectors..” Expert Opinion on Biological Therapy 15, no. 6 (June 2015): 845–55. https://doi.org/10.1517/14712598.2015.1035645.
       Full Text
    • Hemphill, James, Erin K. Borchardt, Kalyn Brown, Aravind Asokan, and Alexander Deiters. “Optical Control of CRISPR/Cas9 Gene Editing..” J Am Chem Soc 137, no. 17 (May 6, 2015): 5642–45. https://doi.org/10.1021/ja512664v.
       Full Text  Link to Item
    • Murlidharan, Giridhar, Travis Corriher, H Troy Ghashghaei, and Aravind Asokan. “Unique glycan signatures regulate adeno-associated virus tropism in the developing brain..” J Virol 89, no. 7 (April 2015): 3976–87. https://doi.org/10.1128/JVI.02951-14.
       Full Text  Link to Item
    • Shen, Shen, Garrett E. Berry, Ruth M. Castellanos Rivera, Roland Y. Cheung, Andrew N. Troupes, Sarah M. Brown, Tal Kafri, and Aravind Asokan. “Functional analysis of the putative integrin recognition motif on adeno-associated virus 9..” The Journal of Biological Chemistry 290, no. 3 (January 2015): 1496–1504. https://doi.org/10.1074/jbc.M114.608281.
       Full Text
    • Ishikawa, Kiyotake, Kenneth M. Fish, Lisa Tilemann, Kleopatra Rapti, Jaume Aguero, Carlos G. Santos-Gallego, Ahyoung Lee, et al. “Cardiac I-1c overexpression with reengineered AAV improves cardiac function in swine ischemic heart failure..” Molecular Therapy : The Journal of the American Society of Gene Therapy 22, no. 12 (December 2014): 2038–45. https://doi.org/10.1038/mt.2014.127.
       Full Text
    • Pleticha, Josef, Lukas F. Heilmann, Christopher H. Evans, Aravind Asokan, Richard Jude Samulski, and Andreas S. Beutler. “Preclinical toxicity evaluation of AAV for pain: evidence from human AAV studies and from the pharmacology of analgesic drugs..” Molecular Pain 10 (September 2, 2014). https://doi.org/10.1186/1744-8069-10-54.
       Full Text
    • O’Reilly, Marina, Howard J. Federoff, Yuman Fong, Donald B. Kohn, Amy P. Patterson, Nabil Ahmed, Aravind Asokan, et al. “Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013..” Human Gene Therapy 25, no. 6 (June 2014): 488–97. https://doi.org/10.1089/hum.2014.045.
       Full Text
    • Murlidharan, Giridhar, Richard J. Samulski, and Aravind Asokan. “Biology of adeno-associated viral vectors in the central nervous system..” Frontiers in Molecular Neuroscience 7 (January 2014). https://doi.org/10.3389/fnmol.2014.00076.
       Full Text
    • Shen, Shen, Andrew N. Troupes, Nagesh Pulicherla, and Aravind Asokan. “Multiple roles for sialylated glycans in determining the cardiopulmonary tropism of adeno-associated virus 4..” Journal of Virology 87, no. 24 (December 2013): 13206–13. https://doi.org/10.1128/JVI.02109-13.
       Full Text
    • Asokan, Aravind, and R Jude Samulski. “An emerging adeno-associated viral vector pipeline for cardiac gene therapy..” Human Gene Therapy 24, no. 11 (November 2013): 906–13. https://doi.org/10.1089/hum.2013.2515.
       Full Text
    • Shen, Shen, Eric D. Horowitz, Andrew N. Troupes, Sarah M. Brown, Nagesh Pulicherla, Richard J. Samulski, Mavis Agbandje-McKenna, and Aravind Asokan. “Engraftment of a galactose receptor footprint onto adeno-associated viral capsids improves transduction efficiency..” The Journal of Biological Chemistry 288, no. 40 (October 2013): 28814–23. https://doi.org/10.1074/jbc.M113.482380.
       Full Text
    • Horowitz, Eric D., K Shefaet Rahman, Brian D. Bower, David J. Dismuke, Michael R. Falvo, Jack D. Griffith, Stephen C. Harvey, and Aravind Asokan. “Biophysical and ultrastructural characterization of adeno-associated virus capsid uncoating and genome release..” Journal of Virology 87, no. 6 (March 2013): 2994–3002. https://doi.org/10.1128/JVI.03017-12.
       Full Text
    • Shen, Shen, Kelli D. Bryant, Junjiang Sun, Sarah M. Brown, Andrew Troupes, Nagesh Pulicherla, and Aravind Asokan. “Glycan binding avidity determines the systemic fate of adeno-associated virus type 9..” Journal of Virology 86, no. 19 (October 2012): 10408–17. https://doi.org/10.1128/JVI.01155-12.
       Full Text
    • Li, Chengwen, Nina Diprimio, Dawn E. Bowles, Matthew L. Hirsch, Paul E. Monahan, Aravind Asokan, Joseph Rabinowitz, Mavis Agbandje-McKenna, and R Jude Samulski. “Single amino acid modification of adeno-associated virus capsid changes transduction and humoral immune profiles..” Journal of Virology 86, no. 15 (August 2012): 7752–59. https://doi.org/10.1128/JVI.00675-12.
       Full Text
    • Denard, Jerome, Cyriaque Beley, Robert Kotin, René Lai-Kuen, Stéphane Blot, Hervé Leh, Aravind Asokan, et al. “Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6..” Journal of Virology 86, no. 12 (June 2012): 6620–31. https://doi.org/10.1128/JVI.00297-12.
       Full Text
    • Horowitz, Eric D., M. G. Finn, and Aravind Asokan. “Tyrosine cross-linking reveals interfacial dynamics in adeno-associated viral capsids during infection..” Acs Chemical Biology 7, no. 6 (June 2012): 1059–66. https://doi.org/10.1021/cb3000265.
       Full Text
    • Asokan, Aravind, David V. Schaffer, and R Jude Samulski. “The AAV vector toolkit: poised at the clinical crossroads..” Mol Ther 20, no. 4 (April 2012): 699–708. https://doi.org/10.1038/mt.2011.287.
       Full Text  Link to Item
    • Li, C., N. Narkbunnam, R. J. Samulski, A. Asokan, G. Hu, L. J. Jacobson, M. J. Manco-Johnson, P. E. Monahan, and P. E. Joint Outcome Study Investigators. “Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia..” Gene Ther 19, no. 3 (March 2012): 288–94. https://doi.org/10.1038/gt.2011.90.
       Full Text  Link to Item
    • Pulicherla, Nagesh, Pradeep Kota, Nikolay V. Dokholyan, and Aravind Asokan. “Intra- and inter-subunit disulfide bond formation is nonessential in adeno-associated viral capsids..” Plos One 7, no. 2 (January 2012). https://doi.org/10.1371/journal.pone.0032163.
       Full Text
    • Gray, Steven J., Vivian W. Choi, Aravind Asokan, Rebecca A. Haberman, Thomas J. McCown, and Richard Jude Samulski. “Production of recombinant adeno-associated viral vectors and use in in vitro and in vivo administration..” Curr Protoc Neurosci Chapter 4 (October 2011): Unit-4.17. https://doi.org/10.1002/0471142301.ns0417s57.
       Full Text  Link to Item
    • Pulicherla, N., and A. Asokan. “Peptide affinity reagents for AAV capsid recognition and purification..” Gene Therapy 18, no. 10 (October 2011): 1020–24. https://doi.org/10.1038/gt.2011.46.
       Full Text
    • Pulicherla, Nagesh, Shen Shen, Swati Yadav, Kari Debbink, Lakshmanan Govindasamy, Mavis Agbandje-McKenna, and Aravind Asokan. “Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer..” Molecular Therapy : The Journal of the American Society of Gene Therapy 19, no. 6 (June 2011): 1070–78. https://doi.org/10.1038/mt.2011.22.
       Full Text
    • Shen, Shen, Kelli D. Bryant, Sarah M. Brown, Scott H. Randell, and Aravind Asokan. “Terminal N-linked galactose is the primary receptor for adeno-associated virus 9..” J Biol Chem 286, no. 15 (April 15, 2011): 13532–40. https://doi.org/10.1074/jbc.M110.210922.
       Full Text  Link to Item
    • Horowitz, Eric D., Marc S. Weinberg, and Aravind Asokan. “Glycated AAV vectors: chemical redirection of viral tissue tropism..” Bioconjugate Chemistry 22, no. 4 (April 2011): 529–32. https://doi.org/10.1021/bc100477g.
       Full Text
    • Kapoor, Amit, Mady Hornig, Aravind Asokan, Brent Williams, Jose A. Henriquez, and W Ian Lipkin. “Bocavirus episome in infected human tissue contains non-identical termini..” Plos One 6, no. 6 (2011). https://doi.org/10.1371/journal.pone.0021362.
       Full Text  Link to Item
    • Phillips, Jana L., Julia Hegge, Jon A. Wolff, R Jude Samulski, and Aravind Asokan. “Systemic gene transfer to skeletal muscle using reengineered AAV vectors..” Methods in Molecular Biology (Clifton, N.J.) 709 (January 2011): 141–51. https://doi.org/10.1007/978-1-61737-982-6_9.
       Full Text
    • Asokan, Aravind. “Reengineered AAV vectors: old dog, new tricks..” Discovery Medicine 9, no. 48 (May 2010): 399–403.
    • Asokan, Aravind, Julia C. Conway, Jana L. Phillips, Chengwen Li, Julia Hegge, Rebecca Sinnott, Swati Yadav, et al. “Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle..” Nat Biotechnol 28, no. 1 (January 2010): 79–82. https://doi.org/10.1038/nbt.1599.
       Full Text  Link to Item
    • Li, Chengwen, Matt Hirsch, Nina DiPrimio, Aravind Asokan, Kevin Goudy, Roland Tisch, and R Jude Samulski. “Cytotoxic-T-lymphocyte-mediated elimination of target cells transduced with engineered adeno-associated virus type 2 vector in vivo..” Journal of Virology 83, no. 13 (July 2009): 6817–24. https://doi.org/10.1128/JVI.00278-09.
       Full Text
    • Li, Chengwen, Kevin Goudy, Matt Hirsch, Aravind Asokan, Yun Fan, Jeff Alexander, Junjiang Sun, et al. “Cellular immune response to cryptic epitopes during therapeutic gene transfer..” Proceedings of the National Academy of Sciences of the United States of America 106, no. 26 (June 16, 2009): 10770–74. https://doi.org/10.1073/pnas.0902269106.
       Full Text
    • Li, C., M. Hirsch, P. Carter, A. Asokan, X. Zhou, Z. Wu, and R. J. Samulski. “A small regulatory element from chromosome 19 enhances liver-specific gene expression..” Gene Therapy 16, no. 1 (January 2009): 43–51. https://doi.org/10.1038/gt.2008.134.
       Full Text
    • Asokan, A., J. S. Johnson, C. Li, and R. J. Samulski. “Bioluminescent virion shells: new tools for quantitation of AAV vector dynamics in cells and live animals..” Gene Ther 15, no. 24 (December 2008): 1618–22. https://doi.org/10.1038/gt.2008.127.
       Full Text  Link to Item
    • Li, Wuping, Aravind Asokan, Zhijian Wu, Terry Van Dyke, Nina DiPrimio, Jarrod S. Johnson, Lakshmanan Govindaswamy, et al. “Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles..” Mol Ther 16, no. 7 (July 2008): 1252–60. https://doi.org/10.1038/mt.2008.100.
       Full Text  Link to Item
    • Li, Wuping, Aravind Asokan, Zhijian Wu, Terry Van Dyke, Nina DiPrimio, Jarrod S. Johnson, Lakshmanan Govindaswamy, et al. “Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological Nanoparticles..” Molecular Therapy : The Journal of the American Society of Gene Therapy 16, no. 7 (July 2008): 1252–60. https://doi.org/10.1038/mt.2008.100.
       Full Text
    • DiPrimio, Nina, Aravind Asokan, Lakshmanan Govindasamy, Mavis Agbandje-McKenna, and R Jude Samulski. “Surface loop dynamics in adeno-associated virus capsid assembly..” J Virol 82, no. 11 (June 2008): 5178–89. https://doi.org/10.1128/JVI.02721-07.
       Full Text  Link to Item
    • Li, Chengwen, Matthew Hirsch, Aravind Asokan, Brian Zeithaml, Hong Ma, Tal Kafri, and R Jude Samulski. “Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo..” J Virol 81, no. 14 (July 2007): 7540–47. https://doi.org/10.1128/JVI.00529-07.
       Full Text  Link to Item
    • Choi, Vivian W., Aravind Asokan, Rebecca A. Haberman, and Richard Jude Samulski. “Production of recombinant adeno-associated viral vectors for in vitro and in vivo use..” Current Protocols in Molecular Biology Chapter 16 (April 2007): Unit-16.25. https://doi.org/10.1002/0471142727.mb1625s78.
       Full Text
    • Choi, Vivian W., Aravind Asokan, Rebecca A. Haberman, and Richard Jude Samulski. “Production of recombinant adeno-associated viral vectors..” Current Protocols in Human Genetics Chapter 12 (April 2007): Unit-12.9. https://doi.org/10.1002/0471142905.hg1209s53.
       Full Text
    • Wu, Zhijian, Aravind Asokan, Joshua C. Grieger, Lakshmanan Govindasamy, Mavis Agbandje-McKenna, and R Jude Samulski. “Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes..” J Virol 80, no. 22 (November 2006): 11393–97. https://doi.org/10.1128/JVI.01288-06.
       Full Text  Link to Item
    • Asokan, Aravind, Julie B. Hamra, Lakshmanan Govindasamy, Mavis Agbandje-McKenna, and Richard J. Samulski. “Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry..” J Virol 80, no. 18 (September 2006): 8961–69. https://doi.org/10.1128/JVI.00843-06.
       Full Text  Link to Item
    • Wu, Zhijian, Aravind Asokan, and R Jude Samulski. “Adeno-associated virus serotypes: vector toolkit for human gene therapy..” Mol Ther 14, no. 3 (September 2006): 316–27. https://doi.org/10.1016/j.ymthe.2006.05.009.
       Full Text  Link to Item
    • Choi, Vivian W., Aravind Asokan, Rebecca A. Haberman, Thomas J. McCown, and Richard Jude Samulski. “Production of recombinant adeno-associated viral vectors and use for in vitro and in vivo administration..” Current Protocols in Neuroscience Chapter 4 (May 2006): Unit-4.17. https://doi.org/10.1002/0471142301.ns0417s35.
       Full Text
    • Asokan, Aravind, and R Jude Samulski. “AAV does the shuffle..” Nat Biotechnol 24, no. 2 (February 2006): 158–60. https://doi.org/10.1038/nbt0206-158.
       Full Text  Link to Item
    • Asokan, Aravind, and Moo J. Cho. “Cytosolic delivery of macromolecules 4. Head group-dependent membrane permeabilization by pH-sensitive detergents..” Journal of Controlled Release : Official Journal of the Controlled Release Society 106, no. 1–2 (August 2005): 146–53. https://doi.org/10.1016/j.jconrel.2005.04.010.
       Full Text
    • Asokan, Aravind, and Moo J. Cho. “Cytosolic delivery of macromolecules. II. Mechanistic studies with pH-sensitive morpholine lipids..” Biochimica Et Biophysica Acta 1611, no. 1–2 (April 2003): 151–60. https://doi.org/10.1016/s0005-2736(03)00050-6.
       Full Text
    • Chen, Feng-Jing, Aravind Asokan, and Moo J. Cho. “Cytosolic delivery of macromolecules: I. Synthesis and characterization of pH-sensitive acyloxyalkylimidazoles..” Biochimica Et Biophysica Acta 1611, no. 1–2 (April 2003): 140–50. https://doi.org/10.1016/s0005-2736(03)00049-x.
       Full Text
    • Asokan, Aravind, and Moo J. Cho. “Exploitation of intracellular pH gradients in the cellular delivery of macromolecules..” J Pharm Sci 91, no. 4 (April 2002): 903–13.
       Link to Item

  • Book Sections

    • Murlidharan, G., R. J. Samulski, and A. Asokan. “Gene therapy of CNS disorders using recombinant AAV vectors.” In Translational Neuroscience: Fundamental Approaches for Neurological Disorders, 9–24, 2016. https://doi.org/10.1007/978-1-4899-7654-3_2.
       Full Text
    • Asokan, A., R. Cheung, and M. J. Cho. “Strategies for the Cytosolic Delivery of Macromolecules: An Overview.” In Handbook of Pharmaceutical Biotechnology, 279–96, 2006. https://doi.org/10.1002/9780470117118.ch3c.
       Full Text

  • Conference Papers

    • Bulaklak, Karen, Jacqueline Robinson-Hamm, Veronica Gough, Christopher E. Nelson, Victoria Madigan, Aravind Asokan, and Charles A. Gersbach. “AAV-Mediated Deletion of a Large Mutational Hotspot for Treatment of Duchenne Muscular Dystrophy.” In Molecular Therapy, 27:377–377. CELL PRESS, 2019.
       Link to Item
    • Castle, Michael J., Yuhsiang Cheng, Aravind Asokan, and Mark H. Tuszynski. “Physical Positioning Dramatically Improves Brain Transduction after Intrathecal Infusion of AAV9.” In Molecular Therapy, 27:97–98. CELL PRESS, 2019.
       Link to Item
    • Gonzalez, Trevor J., Rita Meganck, Marco Fanous, Kate Simon, and Aravind Asokan. “Design Principles for AAV Mediated Circular RNA Expression in the Brain.” In Molecular Therapy, 27:60–60. CELL PRESS, 2019.
       Link to Item
    • Havlik, L Patrick, L Victor Tse, J Kennon Smith, Kelli A. Klinc, Daniel Oh, Katherine Simon, Wenwei Shao, Chengwen Li, Mavis Agbandje-McKenna, and Aravind Asokan. “Engineering A Humanized AAV8 Capsid through Iterative Structure-Guided Evolution.” In Molecular Therapy, 27:53–53. CELL PRESS, 2019.
       Link to Item
    • Madigan, Victoria, Tyne O. Tyson, Julianne A. Yuziuk, Minakshi Pillai, Sven Moller-Tank, and Aravind Asokan. “A CRISPR Screen Identifies Apical Polarity Determinant Crumbs 3 as an AAV Host Restriction Factor.” In Molecular Therapy, 27:424–25. CELL PRESS, 2019.
       Link to Item
    • Madigan, Victoria, Tyne O. Tyson, and Aravind Asokan. “Mass Spectrometric Identification of Host Factors that Restrict AAV Vector Genome Transcription.” In Molecular Therapy, 27:425–425. CELL PRESS, 2019.
       Link to Item
    • Nelson, Christopher, Yaoying Wu, Matthew Gemberling, Matthew Oliver, Joel D. Bohning, Jacqueline N. Robinson-Hamm, Karen Bulaklak, et al. “Long-Term Evaluation of AAV-CRISPR Genome Editing for Duchenne Muscular Dystrophy.” In Molecular Therapy, 27:46–47. CELL PRESS, 2019.
       Link to Item
    • Burwitz, Benjamin, Jochen Wettengel, Martin Muck-Hausl, Katherine Hammond, Marc Ringelhan, Chunkyu Ko, Jason Reed, et al. “A new HIV/HBV co-infection model: hepatocytic expression of human sodium taurocholate cotransporting polypeptide (NTCP) Enables Hepatitis B Virus Infection of Macaques.” In Journal of Medical Primatology, 47:324–324. WILEY, 2018.
       Link to Item
    • Albright, Blake H., Claire Storey, Garth Devlin, Mavis Agbandje-McKenna, and Aravind Asokan. “Capsid-Glycan Receptor Interactions Influence AAV Transport across the Blood-Brain Barrier.” In Molecular Therapy, 26:29–29. CELL PRESS, 2018.
       Link to Item
    • Madigan, Victoria J., Julianne Yuziuk, Longping V. Tse, Anna Chiarella, Tyne Tyson, Nate Hathaway, and Aravind Asokan. “RNF121 is a Key Transcriptional Regulator of AAV Genome Expression.” In Molecular Therapy, 26:27–27. CELL PRESS, 2018.
       Link to Item
    • Meganck, Rita M., Erin K. Bochardt, Ruth M. Castellanos, Miranda L. Scalabrino, Jeremy Wilusz, William F. Marzluff, and Aravind Asokan. “Systemic Expression of Translatable Circular Rnas Using Recombinant AAV Vectors.” In Molecular Therapy, 26:273–273. CELL PRESS, 2018.
       Link to Item
    • Nelson, Christopher, Matthew Gemberling, Matthew L. Oliver, Chady H. Hakim, Ruth M Castellanos Rivera, Aravind Asokan, Dongsheng Duan, and Charles A. Gersbach. “Long-Term Evaluation of Genome Editing Outcomes for Duchenne Muscular Dystrophy.” In Molecular Therapy, 26:431–32. CELL PRESS, 2018.
       Link to Item
    • Robinson-Hamm, Jacqueline N., Christopher E. Nelson, Matthew Gemberling, Veronica Gough, Ruth M Castellanos Rivera, Annemieke Aartsma-Rus, Aravind Asokan, and Charles A. Gersbach. “Dystrophin Restoration in a Humanized Mouse Model of Duchenne Muscular Dystrophy by Gene Editing with S. Aureus Cas9.” In Molecular Therapy, 26:118–19. CELL PRESS, 2018.
       Link to Item
    • Tse, Longping V., Sven Moller-Tank, Rita M. Meganck, Mavis Agbandje-McKenna, and Aravind Asokan. “Mapping and Engineering Functional Domains of the Assembly Activating Protein of Adeno-Associated Viruses.” In Molecular Therapy, 26:27–28. CELL PRESS, 2018.
       Link to Item
    • Albright, Blake, Claire Storey, Giridhar Murlidharan, Ruth Castellanos Rivera, and Aravind Asokan. “Discovery of a Neurotropic Footprint That Enables AAV Transport Across the Blood-Brain Barrier.” In Molecular Therapy, 25:230–31. CELL PRESS, 2017.
       Link to Item
    • Moller-Tank, Sven, Ruth M. Castellanos, Daniel Oh, Longping V. Tse, Miranda L. Scalabrino, and Aravind Asokan. “Expanding the CNS Transduction Profile of AAV4 by Structure-Guided Evolution.” In Molecular Therapy, 25:247–247. CELL PRESS, 2017.
       Link to Item
    • Nelson, Christopher, Matthew Gemberling, Sarina Madhavan, Ruth M Castellanos Rivera, Aravind Asokan, and Charles A. Gersbach. “Long-Term Characterization of In Vivo Genome Editing in a Mouse Model of Duchenne Muscular Dystrophy.” In Molecular Therapy, 25:100–101. CELL PRESS, 2017.
       Link to Item
    • Rivera, Ruth M Castellanos, Austin D. Sun, Marco Fanous, and Aravind Asokan. “Disruption of Water Homeostasis Affects AAV Transport Across the Blood-Brain Barrier.” In Molecular Therapy, 25:109–109. CELL PRESS, 2017.
       Link to Item
    • Robinson-Hamm, Jacqueline N., Christopher E. Nelson, Matthew Gemberling, Ruth M Castellanos Rivera, Annemieke Aartsma-Rus, Aravind Asokan, and Charles A. Gersbach. “Dystrophin Restoration in a Humanized Mouse Model of Duchenne Muscular Dystrophy by Gene Editing with S. aureus Cas9.” In Molecular Therapy, 25:17–17. CELL PRESS, 2017.
       Link to Item
    • Smith, J Kennon S., Yu-Shan Tseng, Daniel Noe, Mathias Kaplan, Lavanya Rao, Robert McKenna, Sergei Zolotukhin, et al. “Structural Mapping of AAV9 Antigenic Sites and the Engineering of Immune Escape Variants.” In Molecular Therapy, 25:337–337. CELL PRESS, 2017.
       Link to Item
    • Tse, Longping V., Kelli A. Klinc, Victoria J. Madigan, Ruth M Castellanos Rivera, Lindsey F. Wells, L Patrick Havlik, J Kennon Smith, Mavis Agbandje-McKenna, and Aravind Asokan. “Structure-Guided Iterative Evolution of Antigenically Advanced AAV Variants for Therapeutic Gene Transfer.” In Molecular Therapy, 25:232–232. CELL PRESS, 2017.
       Link to Item
    • Huang, Lin-Ya, Ami Patel, Robert Ng, Edward B. Miller, Sujata Halder, Robert McKenna, Aravind Asokan, and Mavis Agbandje-McKenna. “727. Characterizing the Adeno-Associated Virus 1 Sialic Receptor Binding Site and Its Overlap with Antigenic Epitopes.” In Molecular Therapy, 24:S287–S287. Elsevier BV, 2016. https://doi.org/10.1016/s1525-0016(16)33535-3.
       Full Text
    • Murlidharan, Giridhar, and Aravind Asokan. “Aquaporins and CSF Flux Are Critical Determinants of AAV Mediated CNS Gene Transfer.” In Molecular Therapy, 24:S24–S24. NATURE PUBLISHING GROUP, 2016.
       Link to Item
    • Robinson-Hamm, Jacqueline N., Christopher E. Nelson, Ruth M Castellanos Rivera, Annemieke Aartsma-Rus, Aravind Asokan, and Charles A. Gersbach. “504. Restoration of Dystrophin Expression by Gene Editing with S. aureus Cas9 in Models of Duchenne Muscular Dystrophy.” In Molecular Therapy, 24:S201–S201. Elsevier BV, 2016. https://doi.org/10.1016/s1525-0016(16)33313-5.
       Full Text
    • Schreiber, Claire A., Yoshihiro Izumiya, Aravind Asokan, and Yasuhiro Ikeda. “8. Further Characterization of U2 snRNP Mediated Restriction of AAV Vector Transduction.” In Molecular Therapy, 24:S4–5. Elsevier BV, 2016. https://doi.org/10.1016/s1525-0016(16)32817-9.
       Full Text
    • Schreiber, C. A., T. Sakuma, Y. Izumiya, R. K. Bressin, U. Basu, K. Koide, A. Asokan, and Y. Ikeda. “Enhanced AAV vector transduction through genetic and pharmacological inhibition of U2 snRNP components.” In Human Gene Therapy, 26:A3–4. MARY ANN LIEBERT, INC, 2015.
       Link to Item
    • Woodard, Kenton, Katharine J. Liang, Thomas Lentz, William Bennett, Aravind Asokan, and Richard Samulski. “Transduction of Mouse Retina by Intravitreal Delivery Using Chimeric Capsids with Altered Glycan Interactions.” In Investigative Ophthalmology & Visual Science, Vol. 56. ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2015.
       Link to Item
    • Albright, Blake H., Victoria Madigan, Lavanya Rao, John A. Chiorini, Mavis Agbandje-McKenna, and Aravind Asokan. “302. Combinatorial Engineering of a Receptor Footprint on AAV Serotype 4 Yields Novel Vectors.” In Molecular Therapy, 23:S122–S122. Elsevier BV, 2015. https://doi.org/10.1016/s1525-0016(16)33911-9.
       Full Text
    • Berry, Garrett E., and Aravind Asokan. “38. Pharmacological Regulation of Vesicular Trafficking as a Strategy to Enhance Recombinant AAV Transduction.” In Molecular Therapy, 23:S17–S17. Elsevier BV, 2015. https://doi.org/10.1016/s1525-0016(16)33643-7.
       Full Text
    • Murlidharan, Giridhar, Lavanya Rao, Dan Wang, Travis Corriher, Kyung Seok-Oh, Guangping Gao, R. Jude Samulski, Alice F. Tarantal, and Aravind Asokan. “14. Next Generation AAV Vectors for Limiting Systemic Leakage and Improving Safety Following CNS Administration.” In Molecular Therapy, 23:S6–S6. Elsevier BV, 2015. https://doi.org/10.1016/s1525-0016(16)33618-8.
       Full Text
    • Murlidharan, Giridhar, and Aravind Asokan. “265. Polysialic Acid as a Novel Regulator of AAV Tropism in the Developing Brain.” In Molecular Therapy, 23:S106–S106. Elsevier BV, 2015. https://doi.org/10.1016/s1525-0016(16)33874-6.
       Full Text
    • Nelson, Christopher E., Ruth M. Castellanos, Fei Ann Ran, Winston Yan, Feng Zhang, Aravind Asokan, and Charles A. Gersbach. “397. Correction of the Dystrophin Gene By the CRISPR/Cas9 System in a Mouse Model of Muscular Dystrophy.” In Molecular Therapy, 23:S157–58. Elsevier BV, 2015. https://doi.org/10.1016/s1525-0016(16)34006-0.
       Full Text
    • Rao, Lavanya, Blake H. Albright, Travis Corriher, Giridhar Murlidharan, and Aravind Asokan. “42. Differential Transduction Profiles of AAV Vectors in a Mouse Model of Human Glycosylation.” In Molecular Therapy, 23:S18–19. Elsevier BV, 2015. https://doi.org/10.1016/s1525-0016(16)33647-4.
       Full Text
    • Rivera, Ruth M Castellanos, Lavanya Rao, Giridhar Murlidharan, Travis Corriher, and Aravind Asokan. “Lymphatic Transport Mediates Systemic Leakage of Peripherally Administered AAV9 Vectors.” In Molecular Therapy, 23:S77–S77. NATURE PUBLISHING GROUP, 2015.
       Link to Item
    • Schreiber, Claire, Toshie Sakuma, Yoshihiro Izumiya, Sara Holditch, Raymond Hickey, Robert Bressin, Upamanyu Basu, Kazunori Koide, Aravind Asokan, and Yasuhiro Ikeda. “41. U2 snRNP Spliceosome Proteins Block Recombinant AAV Vector Transduction.” In Molecular Therapy, 23:S18–S18. Elsevier BV, 2015. https://doi.org/10.1016/s1525-0016(16)33646-2.
       Full Text
    • Huang, Lin-Ya, Robert Ng, Edward B. Miller, Robert McKenna, Aravind Asokan, and Mavis Agbandje-McKenna. “Characterizing Essential Receptor Binding Residues for AAV1.” In Molecular Therapy, 22:S2–S2. NATURE PUBLISHING GROUP, 2014.
       Link to Item
    • Simpson, Elizabeth M., Charles N. de Leeuw, Siu Ling Lam, Andrea J. Korecki, Russell J. Bonaguro, Kaelan Wong, Michelle Zhou, et al. “Regional-CNS MiniPromoters for AAV Are Identified in a High Through-Put Pipeline.” In Molecular Therapy, 22:S112–S112. NATURE PUBLISHING GROUP, 2014.
       Link to Item
    • Tseng, Yu-Shan, Kim Van Vliet, Matias Kaplan, J Kennon Smith, Lavanya Rao, Robert McKenna, Barry J. Byrne, Sergei Zolotukhin, Aravind Asokan, and Mavis Agbandje-McKenna. “Mapping the Antigenic Structure of Adeno-Associated Virus Serotypes 8 and 9.” In Molecular Therapy, 22:S1–S1. NATURE PUBLISHING GROUP, 2014.
       Link to Item
    • Murlidharan, Giridhar, Laura Sommerville, Troy Ghashghaei, and Aravind Asokan. “Re-Engineering Capsid-Glycan Interactions Expands the CNS Transduction Profile of AAV Serotype 4.” In Molecular Therapy, 21:S1–S1. NATURE PUBLISHING GROUP, 2013.
       Link to Item
    • Shen, Shen, Andrew Troupes, Nagesh Pulicherla, and Aravind Asokan. “Sialic Acids and Erythrocyte Interactions Are Critical Determinants of Cardiopulmonary Tropism Displayed by AAV Serotype 4.” In Molecular Therapy, 21:S31–S31. NATURE PUBLISHING GROUP, 2013.
       Link to Item
    • Shen, Shen, and Aravind Asokan. “Integrins Play a Pivotal Role in Transvascular Transport and Tissue Uptake of AAV9 In Vivo.” In Molecular Therapy, 21:S30–S30. NATURE PUBLISHING GROUP, 2013.
       Link to Item
    • Denard, Jerome, Cyriaque Beley, Robert Kotin, Rene Lai-Kuen, Stephane Blot, Herve Leh, Aravind Asokan, et al. “Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6.” In Human Gene Therapy, 23:A122–A122. MARY ANN LIEBERT INC, 2012.
       Link to Item
    • Horowitz, Eric D., and Aravind Asokan. “Vector Genome Length and Self-Complementarity Affect AAV Capsid Uncoating.” In Molecular Therapy, 20:S202–S202. NATURE PUBLISHING GROUP, 2012.
       Link to Item
    • Shen, Shen, Junjiang Sun, Matthew Hirsch, Sai Chavala, Paul Monahan, and Aravind Asokan. “Altering Tissue Glycan Patterns Improves the Transduction Profile of AAV9 Vectors.” In Molecular Therapy, 20:S203–S203. NATURE PUBLISHING GROUP, 2012.
       Link to Item
    • Monahan, P. E., C. Li, N. Narkbunnam, R. J. Samulski, G. Hu, A. Asokan, and M. J. Manco-Johnson. “Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia.” In Journal of Thrombosis and Haemostasis, 9:231–32. WILEY-BLACKWELL, 2011.
       Link to Item
    • Xiao, Ping-Jie, Jarrod S. Johnson, Aaron Neumann, Xinghua Zeng, Aravind Asokan, and Richard J. Samulski. “Imaging Trafficking Dynamics of Ultra-Pure Single Adeno-Associated Virus in Live Cells.” In Molecular Therapy, 17:S38–S38. NATURE PUBLISHING GROUP, 2009.
       Link to Item
    • Asokan, Aravind, Jarrod S. Johnson, and Richard J. Samulski. “739. Bioluminescent Virion Shells: A Novel Tool for Visualization of Viral Vectors in Animal Tissue.” In Molecular Therapy, 13:S286–S286. Elsevier BV, 2006. https://doi.org/10.1016/j.ymthe.2006.08.821.
       Full Text
    • Asokan, Aravind, Julie B. Hamra, Mavis Agbandje-McKenna, and Richard J. Samulski. “7. Adeno-Associated Virus Type 2 (AAV2) Contains an Integrin alpha5beta1 Recognition Sequence Essential for Viral Cell Entry.” In Molecular Therapy, 13:S3–S3. Elsevier BV, 2006. https://doi.org/10.1016/j.ymthe.2006.08.017.
       Full Text
    • DiPrimio, Nina, Aravind Asokan, and Richard J. Samulski. “104. Role of the HI Loop in the Adeno- Associated Virus (AAV) Life Cycle.” In Molecular Therapy, 13:S43–S43. Elsevier BV, 2006. https://doi.org/10.1016/j.ymthe.2006.08.124.
       Full Text
    • Asokan, Arvind, and Richard J. Samulski. “From crystal structure to clinic: highlights of the Tenth International Parvovirus Workshop..” In Mol Ther, 11:656–60, 2005.
       Link to Item
    • Asokan, Aravind, and Moo J. Cho. “Cytosolic delivery of macromolecules. 3. Synthesis and characterization of acid-sensitive bis-detergents..” In Bioconjugate Chemistry, 15:1166–73, 2004. https://doi.org/10.1021/bc049880n.
       Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.